Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World Study.

Pigment Cell Melanoma Res · 2025 · PMC12127241 · PMID 40451782

Europe PMC DOI

hedged sentence

0.0850

closest p · 1.7× alpha

0.0850

boldest claim

The sentences

a trend toward significancep = 0.085so close (0.05 < p ≤ 0.1)

A trend toward significance in DDI‐L responder patients with a better OS ( p = 0.085, Figure S4A ) was evidenced.

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.